chromosome 2q32-q33 deletion syndrome
chromosome 2q32-q33 deletion syndrome
Explore linked clinical trials. Standard reference: MONDO:00128641 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device | cancer, chromosome 2q32-q33 deletion syndrome, neoplasm | Active, not recruiting | Not applicable | 2026-09-28 | NCT06192758 |